Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) EBT Margin (2024 - 2025)

Historic EBT Margin for Nuvation Bio (NUVB) over the last 2 years, with Q3 2025 value amounting to 425.24%.

  • Nuvation Bio's EBT Margin rose 52432600.0% to 425.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 813.07%, marking a year-over-year increase of 238067700.0%. This contributed to the annual value of 7213.76% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Nuvation Bio reported EBT Margin of 425.24% as of Q3 2025, which was up 52432600.0% from 1220.92% recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's EBT Margin peaked at 425.24% during Q3 2025, and registered a low of 32229.41% during Q2 2024.